Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer

Immunogenic cell death (ICD) can be exploited to treat non-immunoreactive tumors that do not respond to current standard and innovative therapies. Not all chemotherapeutics trigger ICD, among those that do exert this effect, there are anthracyclines, irinotecan, some platinum derivatives and oncolyt...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Alessandro Rencinai, Eva Tollapi, Giulia Marianantoni, Jlenia Brunetti, Tania Henriquez, Alessandro Pini, Luisa Bracci, Chiara Falciani
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-10-01
Edice:	Frontiers in Molecular Biosciences
Témata:	immunogenic cell death pancreatic cancer oncolytic peptides danger associated molecular patterns metastasis
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fmolb.2024.1429163/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!